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Abstract
Introduction: Peripheral primitive neuroectodermal tumors of the urinary bladder are rare and
tend to occur in an older age group than do their counterparts in bones and soft tissue.
Case presentation: We report a case of peripheral primitive neuroectodermal tumor of the
urinary bladder in a 67-year-old woman of Arab origin. She had undergone transurethral resection
followed by chemotherapy because of pulmonary metastasized muscle-invasive squamous cell
carcinoma of the bladder in 2005. One year later, she first presented with a history of repeated
hematuria in our institution. Performing cystoscopy any tumor could be detected. Control
cystoscopy two months later showed a tumor mass of 3 cm in diameter at another location than
described for the first tumor. After perforating by transurethral resection partial bladder resection
had to be done. Tissue specimen after pathological analysis revealed a peripheral primitive
neuroectodermal tumor with tumor cells reactive to cluster of differentiation 99, neuron-specific
enolase and S100 protein and stained negative for other markers such as cytokeratins, epithelial
membrane antigen, desmin, smooth muscle actin, chromogranin and leucocyte common antigen.
Staging computerized tomography was especially free from any hint on organ metastasis, but the
patient died due to a cardiac problem only a few months later.
Conclusions: Tothebestofourknowledge,wereporttheeighthcaseofbladderperipheralprimitive
neuroectodermal tumors in literature and the first concerning an Arab patient. It is also the first
presentation of a peripheral primitive neuroectodermal tumor patient with a history of squamous cell
carcinoma of the bladder. As in other cases, expression of single-chain-type 1 glycoprotein and neural
markers was positive and the disease was at an advanced stage at the time of diagnosis.
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Peripheral primitive neuroectodermal tumors(pPNET) are
malignant small round-cell tumors that occur predomi-
nantly in bones and soft tissue of children and young
adults [1], only in rare cases in other organs and in older
patients [2]. pPNET belong to the Ewing’s sarcoma family
of tumors and share the same immunohistochemical
profiles and molecular genotypes [3]. Tumor cell staining
of these masses was shown to be positive for MIC2 gene
product (CD99) and neural markers such as neuron-
specific enolase (NSE), vimentin, S100 protein or synap-
tophysin [3–6]. Primitive neuroectodermal tumors of the
urinary tract are very rare, more often occurring in renal
masses than as bladder tumors [3]. To our knowledge,
only 7 cases of primary pPNET of the urinary bladder have
been reported so far [3–9], often concerning much older
patients than those presenting with neuroectodermal
tumors of other organs [5–7]. Poor prognosis necessitates
multimodal treatment with chemotherapy and radio-
therapy, following surgical measures [3].
Case presentation
We report the first case of a peripheral primitive
neuroectodermal tumor of the urinary bladder in an
Arab country. The Department of Surgery of Al Sabah
Hospital, Kuwait admitted a 67-year-old diabetic and
hypertensive Arab woman in February 2006, due to severe
hematuria and fever. In January 2005, the woman had
already been treated in a hospital of Great Britain for
repeated hematuria for the duration of one year. During
this initial admission, cystoscopy revealed an intrinsic
urinary bladder mass that was resected. Histologically, it
was reported as poorly differentiated squamous cell
carcinoma (pT2G3). Computerized tomography (CT)
scan showed diffuse but irregular thickening of thebladder
wall, pelvic lymphadenopathy and multiple small bilat-
eral pulmonary metastases. Mild hydronephrosis was
noted in the right kidney, other abdominal organs were
essentially normal. The patient received three courses
chemotherapy, to which her response was excellent, and
was discharged home in good condition. In November
2005, the patient underwent a follow-up cystoscopy that
showed a recurrent malignant urinary bladder tumor
which was completely resected. A CT scan of thorax,
abdomen and pelvis, that did not show evidence of cancer
progression, and a negative bone scan completed the
follow-up.
On first admission at our institution in February 2006, the
patient was pale and pyretic. Her hemoglobin was 7.7 g/dl
and the blood culture showed an E. coli infection.
Ultrasonography revealed hydronephrosis on the right
side and a thick bladder wall without apparent masses,
verified by cystoscopy. Based on the sensitivity report, she
was treated with ciprofloxacin and a 3-way irrigation
catheter was inserted to rinse the bladder. Although her
general condition improved, mild hematuria persisted.
Follow-up cystoscopy in April 2006 showed a tumor
located at the posterior wall and the dome of the urinary
bladder (another site than described for the squamous cell
carcinoma). As an initial attempt at transurethral resection
(TUR) resulted in perforation, a partial bladder resection
was performed. A post-surgery CT of the thorax, abdomen
and pelvis showed mild dilatation of the right renal pelvis,
a thickened urinary bladder wall without an exophytic
mass and no evidence of lung metastasis. The tumor
specimen gained during surgery consisted of grey-brown
tissue measuring 3 × 2.5 × 1 cm. Pathohistology showed
features of a malignant small round-cell tumor (Figures 1
and 2), with frequent mitosis, apoptosis, necrosis, vascular
invasion and deep infiltration of the muscularis propria.
The tumor cells expressed CD99 (MIC2 gene, Figure 3),
NSE and S100 protein, but were non-reactive to cytoker-
atins, epithelial membrane antigen, desmin, smooth
muscle actin, chromogranin and leucocyte common
antigen. A diagnosis of peripheral primitive neuroecto-
dermal tumor (pPNET) obviously due to secondary tumor
Figure 1.
Malignant small round-cells arranged in irregular masses and
clusters. Tumor is seen above the muscularis propria of the
bladder wall in this field (HE, 40x).
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good condition but died of cardiac-related problems in
October 2006.
Discussion and conclusions
Peripheral primitive neuroectodermal tumors (pPNET) of
the urinary bladder are rare, aggressive masses that partly
tend to occur at a much older age than do their bone and
soft tissue counterparts in the Ewing’s sarcoma family. It is
said, that concerned patients are either of young age like in
other small round-cell tumors [4, 8, 9] or of advanced age
[5–7] as inour case. In this age group, these tumors maybe
confused with the more frequent transitional cell carcino-
mas. Besides, pPNET must be differentiated from other
rare tumors of the urinary bladder, such as embryonal
rhabdomyosarcoma that may also occur in older age
groups [10]. However, pPNET following or preceeding
squamous cell carcinoma as in our case presentation was
never reported before. Immunohistochemistry and, where
available, molecular biology, are considered necessary in
the evaluation of undifferentiated or poorly differentiated
bladder tumors. In the present case, the immunohisto-
chemistry profile supported the diagnosis of pPNET. As in
most reported cases of pPNET, our patient showed
positivity for neuron-specific enolase and MIC2 gene [3,
5, 6, 8]. Other neural markers showed different results in
pPNET diagnostics. Whereas S100 protein was positive in
our case, this marker showed different results in other
pPNET patients with positive [3, 4, 6] and negative
staining [8, 9]. Cytokeratins, epithelial membrane antigen,
desmin (CD33), smooth muscle actin, chromogranin and
leucocyte common antigen (CD3 und CD20) were not
significant markers in this case, in accordance with the
results of Desai and Banerjee et al [8,9].
Patients in some cases already had metastases at the time
of diagnosis and this suggested a poor prognosis [5–8],
however, it must be noted that the outcome of pPNET of
the urinary bladder cannot be predicted. On the one hand,
this is due to its rarity and thus missing long-term data,
and, on the other hand, because it often affects older
people with concomitant diseases, which may render
differentiation of cause of death difficult. While our
patient died soon after discharge of cardiac-related
problems after a symptomatic period of 30 months of
bladder tumor disease (squamous cell carcinoma and
pPNET) in total, disease-free survival durations of up to
3 years have been reported [4].
List of abbreviations
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Figure 2.
Predominantly small cells with round vesicular nuclei arranged
in diffuse sheet (HE, 200x).
Figure 3.
The small round-cells of the pPNET in our case showed
positivity for MIC2 gene (CD99+) (400x).
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